News & Perspective

Dec 28, 2012

Dec 28, 2012

Flu markers keep climbing in US and Europe

Editor's Note: The fourth paragraph was revised on Jan 2 to clarify the current situation regarding H3N2 dominance.

(CIDRAP News) – US influenza activity continued its ascent last week, judging from the high volumes of patients seeking care for the disease at doctors' offices, while flu indicators in Europe showed a clear spike, according to the latest surveillance reports.

Dec 21, 2012

Dec 21, 2012

Flu pace picks up in US, Canada, parts of Europe

(CIDRAP News) – Flu activity in the Northern Hemisphere continued to climb last week, led by a vigorous pace of infections in the United States and Canada in the lead-up to the Christmas holiday season, the World Health Organization (WHO) said today.

Dec 20, 2012

Dec 20, 2012

Attack rate in fungal meningitis outbreak estimated at 4.4%

(CIDRAP News) – Researchers estimate from preliminary data that 4.4% of patients who were exposed to contaminated steroid drugs from a Massachusetts compounding pharmacy contracted fungal meningitis or other fungal infections, according to a new report in the New England Journal of Medicine.

Dec 14, 2012

Dec 14, 2012

US sees more flu activity, finds another H3N2v case

(CIDRAP News) – Influenza activity continued its early-season upward trend in the United States last week, while the flu season showed some signs of getting under way in Europe. In addition, US investigators found another case of swine-origin H3N2 flu, this one in a Minnesotan who has recovered.

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»